CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS

Details for Australian Patent Application No. 2003272189 (hide)

Owner CYTOVIA, INC.

Inventors CAI, Sui, Xiong; TSENG, Ben, Y.

Pub. Number AU-A-2003272189

PCT Number PCT/US03/10645

PCT Pub. Number WO2004/002401

Priority 60/369,806 05.04.02 US

Filing date 7 April 2003

Wipo publication date 19 January 2004

Event Publications

22 January 2004 Complete Application Filed

  Priority application(s): 60/369,806 05.04.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-A-2003272189

7 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003272190-HIGH ALTITUDE PLATFORM DEPLOYMENT SYSTEM

2003272188-UTILIZATION OF MHC CLASS II BINDING MOTIFS IN IMMUNIZATION TO PRODUCE IMMUNE SERUM, MONOCLONAL ANTIBODIES AND VACCINES